Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0300 USD
−3.35 M USD
1.96 M USD
65.71 M
About PURE Bioscience
Sector
CEO
Robert F. Bartlett
Headquarters
El Cajon
Website
Founded
1992
FIGI
BBG000BVNM59
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PURE is 0.0630 USD — it has increased by 9.00% in the past 24 hours. Watch PURE Bioscience stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PURE Bioscience stocks are traded under the ticker PURE.
PURE stock has risen by 6.34% compared to the previous week, the month change is a −34.87% fall, over the last year PURE Bioscience has showed a −52.27% decrease.
PURE reached its all-time high on Nov 14, 2007 with the price of 558.0800 USD, and its all-time low was 0.0590 USD and was reached on Jun 26, 2024. View more price dynamics on PURE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PURE stock is 9.37% volatile and has beta coefficient of −0.66. Track PURE Bioscience stock price on the chart and check out the list of the most volatile stocks — is PURE Bioscience there?
Today PURE Bioscience has the market capitalization of 7.56 M, it has increased by 1.16% over the last week.
Yes, you can track PURE Bioscience financials in yearly and quarterly reports right on TradingView.
PURE Bioscience is going to release the next earnings report on Dec 12, 2024. Keep track of upcoming events with our Earnings Calendar.
PURE net income for the last quarter is −756.00 K USD, while the quarter before that showed −857.00 K USD of net income which accounts for 11.79% change. Track more PURE Bioscience financial stats to get the full picture.
No, PURE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 12.00 employees. See our rating of the largest employees — is PURE Bioscience on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PURE Bioscience EBITDA is −2.98 M USD, and current EBITDA margin is −151.96%. See more stats in PURE Bioscience financial statements.
Like other stocks, PURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURE Bioscience stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURE Bioscience technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURE Bioscience stock shows the sell signal. See more of PURE Bioscience technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.